Given that EGFR amplification, TERT mutations, and chromosome +7/-10 are often observed simultaneously, these three factors have been included in the WHO 2021 classification of central nervous system tumors as diagnostic criteria for IDHwt-GBM.28 This evidence concerns the gene EGFR and glioblastoma.